FDA Approval Decisions Report
Abstract
The Revere FDA Approval Decision Report report provides one of the most comprehensive and accurate event calendars for PDUFA dates (Prescription Drug User Fee Act) -- expected FDA approval dates for NDA/BLA filed drugs in the next 3 months and reviews all FDA approval decisions in the current month.
Furthermore, the report also analyzes each drug candidate's likelihood of approval and competitive landscape using 3 criteria derived from Revere's patented classification system:
- Utilization of a mechanism of action previously approved by the FDA.
- Facing two or fewer alternative drugs with the same mechanism of action for the same indication.
- Would be the first or second FDA approved drug for the company.
Subscribe to an RSS Feed Featured Reports
- FDA Approval Decisions Report for September, 2010 Revere - Sep 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for August, 2010 Revere - Aug 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for July, 2010 Revere - Jul 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for June, 2010 Revere - Jun 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for May, 2010 Revere - May 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for April, 2010 Revere - Apr 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for March, 2010 Revere - Mar 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for February, 2010 Revere - Feb 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for January, 2010 Revere - Jan 01, 2010 - ZIP - $125.00 - Add to Cart »
- FDA Approval Decisions Report for December, 2009 Revere - Dec 01, 2009 - ZIP - $125.00 - Add to Cart »
Samples
- FDA Approval Decisions Report for Nov, 2006 Revere - Nov 01, 2006 - PDF - View Report »